Arginine is one of the most versatile semi-essential amino acids. Further to the primary role in protein biosynthesis, arginine is involved in the urea cycle, and it is a precursor of nitric oxide. Arginine deficiency is associated with neurodegenerative diseases such as Parkinson's, Huntington's and Alzheimer's diseases (AD). In this study, we administer arginine intracerebroventricularly in a murine model of AD and evaluate cognitive functions in a set of behavioral tests. In addition, the effect of arginine on synaptic plasticity was tested electrophysiologically by assessment of the hippocampal long-term potentiation (LTP). The effect of arginine on β amyloidosis was tested immunohistochemically. A role of arginine in the prevention of cytotoxicity and apoptosis was evaluated in vitro on PC-12 cells. The results indicate that intracerebroventricular administration of arginine improves spatial memory acquisition in 3xTg-AD mice, however, without significantly reducing intraneuronal β amyloidosis. Arginine shows little or no impact on LTP and does not rescue LTP deterioration induced by Aβ. Nevertheless, arginine possesses neuroprotective and antiapoptotic properties.
Introduction
Alzheimer's disease is a slowly progressive neurodegenerative disorder with prevalence among elderly people and women (Hebert et al. 2013 ). The AD is characterized morphologically by diffuse neuritic plaques containing Aβ peptide and neurofibrillary tangles, which are aggregates of hyperphosphorylated tau protein (Schaeffer et al. 2011 ). The exact cause of AD is unknown, and several studies have attenuates the increased platelet reactivity in hypercholesterolemic patients (Wolf et al. 1997 ) and prevents atherogenesis (Cooke et al. 1992 ). 
Arginine metabolism as a target for treatment of AD
Arginine is a conditionally essential α-amino acid that is used in the biosynthesis of proteins.
Arginine possesses a broad spectrum of regulatory functions, which are predicated upon its chemical structure and activity. An overwhelming review of the possible physiological effects of the amino acid upon the development of AD has been done by Yi et al (Yi et al. 2009 ).
Quite a lot of vital metabolites, (i.e., NO, urea) are derived from it, and their cytoprotective and antioxidant properties are presently well known. The well-marked cationic properties of the guanidine group of arginine contribute to its ability to undergo protonation. It is well established that arginine derivatives and the amino acid itself can regulate peroxidation processes in membranes (Milyutina 1990 ).
Evidently, arginine reacts directly with the superoxide anion-radical that may be a basis for its protective effects under extreme conditions. 
Materials and Methods

Mouse strains
There are several animal models of the AD which were created to study the disease. Subsequently, MTT reagent (final concentration, 0.5 mg/mL) was added to each of the wells, and the plate was incubated for three hours at 37 °C.
Cell viability assays
At the end of the incubation, the medium with MTT was removed and 100 μL DMSO was added to each well. The formazan reduction product was measured by reading absorbance at 570 nm in a microplate reader (Infinite® M1000).
Cell viability was presented as a percentage of the control culture. 
Behavioral tests Morris water maze (MWM)
The 
Imaging and quantification
The number of Aβ deposits throughout the hippocampi (3-6 sections examined per mouse) was quantified. Imaging was done using a Nikon Eclipse E600 microscope equipped with a 
Antibody microarray analyses
The evaluation of "hit" proteins' expression or phosphorylation of specific residues on Finally, Cytoscape software was applied for the topological analysis and network visualization of the priority genes.
Electrophysiology
Male six months old C57BL/6 mice were anesthetized with isoflurane and decapitated.
Brains were quickly removed and submerged in ice-cold dissection solution (concentrations in mM: 124 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, were adjusted to 2.5 and 1.3, respectively).
Slices were heated to 36°C in water bath for 40 min and then kept at room temperature.
Amyloid β peptide (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) 
Statistical analysis
Statistical analyses were conducted using SPSS 
Administration of L-arginine has no significant impact on the rate of Aβ deposition
Immunohistochemistry was employed to detect deposits of intra-and extraneuronal Aβ in the hippocampi of brain slices from treated (n=5) and untreated (n=5) 3xTg-AD mice.
Multiple intracellular deposits of amyloid beta and scarce plaques have been detected in the cortices, amygdala, and hippocampi. There were no significant differences in the amount of amyloid beta deposition between two groups aggregation and apoptotic bodies. Arginine mitigates these morphological changes of the nuclei, which was consistent with the MTT results in Fig. 6 .
The rate of cell apoptosis in the plates with no arginine was significantly higher than that in the experimental plates.
L-arginine protects cells against Aβ(25-35) and Hydrogen peroxideinduced toxicity in a concentrationdependent manner
To study the effect of L-arginine on cell viability in the Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) 
